ABT - ABBOTT LABORATORIES

QQQ $ 592.41 $ -19.22 (-3.14 %)

DIA $ 459.61 $ -7.08 (-1.52 %)

SPY $ 658.03 $ -15.06 (-2.24 %)

TLT $ 89.33 $ 0.34 (0.38 %)

GLD $ 372.71 $ -2.40 (-0.64 %)

Previous Close

$ 126.15

Open

$ 122.70

Bid

$ 124.68 x 1

Ask

$ 124.75 x 51

Day's Range

$ 122.34 - $ 125.61

52 Week Range

$ 109.21 - $ 139.33

Volume

10,296,518

Average Volume

Market Cap

219.36B

Beta (5Y Monthly)

$ 0.55

PE Ratio (TTM)

$ 15.69

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.02)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	10-29-2025	09-30-2025	10-Q
2	07-30-2025	06-30-2025	10-Q
3	04-30-2025	03-31-2025	10-Q
4	02-21-2025	12-31-2024	10-K
5	10-31-2024	09-30-2024	10-Q
6	07-31-2024	06-30-2024	10-Q
7	05-02-2024	03-31-2024	10-Q
8	02-16-2024	12-31-2023	10-K
9	11-01-2023	09-30-2023	10-Q
10	08-03-2023	06-30-2023	10-Q
11	05-04-2023	03-31-2023	10-Q
12	02-17-2023	12-31-2022	10-K
13	11-01-2022	09-30-2022	10-Q
14	08-02-2022	06-30-2022	10-Q
15	05-03-2022	03-31-2022	10-Q
16	02-18-2022	12-31-2021	10-K
17	11-03-2021	09-30-2021	10-Q
18	08-04-2021	06-30-2021	10-Q
19	05-05-2021	03-31-2021	10-Q
20	02-19-2021	12-31-2020	10-K
21	11-04-2020	09-30-2020	10-Q
22	07-29-2020	06-30-2020	10-Q
23	04-29-2020	03-31-2020	10-Q
24	02-21-2020	12-31-2019	10-K
25	10-31-2019	09-30-2019	10-Q
26	07-31-2019	06-30-2019	10-Q
27	05-01-2019	03-31-2019	10-Q
28	02-22-2019	12-31-2018	10-K
29	10-31-2018	09-30-2018	10-Q
30	08-01-2018	06-30-2018	10-Q
31	05-02-2018	03-31-2018	10-Q
32	02-16-2018	12-31-2017	10-K
33	11-02-2017	09-30-2017	10-Q
34	08-02-2017	06-30-2017	10-Q
35	05-03-2017	03-31-2017	10-Q
36	02-17-2017	12-31-2016	10-K
37	11-03-2016	09-30-2016	10-Q
38	08-03-2016	06-30-2016	10-Q
39	05-04-2016	03-31-2016	10-Q
40	02-19-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

abbotts-21-billion-exact-sciences-buyout-reshapes-cancer-diagnostics

Abbott's $21 Billion Exact Sciences Buyout...
11/20/2025 14:37:44

Abbott will acquire Exact Sciences for $21 billion, adding Cologuard and expanding its diagnostics portfolio as analysts highli...

Abbott Signs Agreement To Acquire Exact Sc...
11/20/2025 12:31:56

Abbott (NYSE:ABT) and Exact Sciences (NASDAQ:EXAS) today announced a definitive agreement for Abbott to acquire Exact Sciences,...

BTIG Reiterates Buy on Abbott Laboratories...
11/20/2025 10:22:49

BTIG analyst Marie Thibault reiterates Abbott Laboratories (NYSE:ABT) with a Buy and maintains $145 price target.

UPDATE: 'Abbott Weighs Takeover of Cancer ...
11/19/2025 18:41:40

https://www.bloomberg.com/news/articles/2025-11-19/abbott-weighs-takeover-of-cancer-test-maker-exact-sciences

what-does-the-market-think-about-abbott-laboratories

What Does the Market Think About Abbott La...
11/14/2025 15:00:34

Is the Market Bullish or Bearish on Abbott...
10/28/2025 18:01:18

A Look Into Abbott Laboratories Inc's Pric...
10/22/2025 15:02:06

CORRECTION: Abbott Laboratories Reported Q...
10/21/2025 14:39:33

Abbott Says Walmart Is First U.S. Retailer...
10/21/2025 13:01:11

- Reuters

Barclays Maintains Overweight on Abbott La...
10/17/2025 13:19:13

Barclays analyst Matt Miksic maintains Abbott Laboratories (NYSE:ABT) with a Overweight and raises the price target from $15...

analyst-sees-noise-in-q3-pl-affirms-abbotts-medtech-strength

Analyst Sees Noise In Q3 P&L, Affirms Abbo...
10/16/2025 17:52:03

Abbott eyes 10% EPS growth in 2026 with CGM momentum, new nutrition contracts, and medical device launches driving global expan...

these-analysts-revise-their-forecasts-on-abbott-following-q3-results

These Analysts Revise Their Forecasts On A...
10/16/2025 16:50:42

Raymond James Maintains Outperform on Abbo...
10/16/2025 16:07:48

Raymond James analyst Jayson Bedford maintains Abbott Laboratories (NYSE:ABT) with a Outperform and raises the price target ...

Evercore ISI Group Maintains Outperform on...
10/16/2025 14:48:29

Evercore ISI Group analyst Vijay Kumar maintains Abbott Laboratories (NYSE:ABT) with a Outperform and lowers the price targe...

RBC Capital Reiterates Outperform on Abbot...
10/16/2025 13:59:19

RBC Capital analyst Shagun Singh reiterates Abbott Laboratories (NYSE:ABT) with a Outperform and maintains $147 price target.

Wells Fargo Maintains Overweight on Abbott...
10/16/2025 13:45:07

Wells Fargo analyst Lawrence Biegelsen maintains Abbott Laboratories (NYSE:ABT) with a Overweight and raises the price targe...

gold-gains-over-1-abbott-shares-fall-after-q3-results

Gold Gains Over 1%; Abbott Shares Fall Aft...
10/15/2025 18:20:16

bank-earnings-lift-wall-street-gold-hits-4200-whats-moving-markets-wednesday

Bank Earnings Lift Wall Street, Gold Hits ...
10/15/2025 17:06:54

Wall Street rose on Wednesday, with investor optimism lifted by strong bank and corporate earnings alongside growing expectatio...

abbott-tightens-annual-sales-forecast-as-q3-sales-miss-expectations

Abbott Tightens Annual Sales Forecast As Q...
10/15/2025 13:16:02

Abbott stock fell as Q3 sales missed estimates and 2025 earnings guidance was narrowed despite solid growth in medical devices.

stock-market-today-sp-500-nasdaq-futures-rise-bank-of-america-morgan-stanley-abbott-earnings-in-focus-updated

Stock Market Today: S&P 500, Nasdaq Future...
10/15/2025 13:05:49

Editor’s note: The future prices of benchmark tracking ETFs, the lede, and the latest economic releases were updated in the sto...

Dysfunction, Heartbreak And Love: 11 Most ...
02/14/2017 22:40:07